Cart
sales@molnova.com
Aristololactam I
CAS No. 13395-02-3
Aristololactam I( —— )
Catalog No. M17961 CAS No. 13395-02-3
Aristololactam I has cytotoxic potency, mediated through the induction of apoptosis in a caspase 3-dependent pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 129 | In Stock |
|
| 10MG | 205 | In Stock |
|
| 25MG | 350 | In Stock |
|
| 50MG | 516 | In Stock |
|
| 100MG | 734 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAristololactam I
-
NoteResearch use only, not for human use.
-
Brief DescriptionAristololactam I has cytotoxic potency, mediated through the induction of apoptosis in a caspase 3-dependent pathway.
-
DescriptionAristololactam I has cytotoxic potency, mediated through the induction of apoptosis in a caspase 3-dependent pathway. The effects of Aristololactam I may be mediated by different mechanisms except TGF-beta1 pathway. 3. Aristololactam I may be one of toxic metabolites in Chinese herbs containing AA which participate in renal damage and fibrosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorCaspase-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13395-02-3
-
Formula Weight293.27
-
Molecular FormulaC17H11NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.5 mg/mL (42.62 mM)
-
SMILESCOC1=CC=CC2=C3C4=C(C=C21)NC(=O)C4=CC5=C3OCO5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SP 4206
SP 4206 is a high-affinity (Kd=70 nM) small molecule that blocks blocks the binding of the IL-2α receptor (IL-2Rα) to IL-2.
-
Kansuinine A
Kansuinine A, a 95% ethanol extract from the roots of E. kansui, possesses an inhibitory effect on IL-6-induced Stat3 activation by activating ERK1/2.
-
Vilazodone HCl
Vilazodone HCl, a partial agonist of 5-HT1A receptors and specific serotonin reuptake inhibitor (SSRI), is utilized in treating of the major depressive disorder.
